Polychlorinated biphenyls in prospectively collected serum and Parkinson's disease risk

Movement Disorders

Volumn 27, Issue 13, 2012, Pages 1659-1665

  Weisskopf, Marc G ^a,b   Knekt, Paul ^c   O'Reilly, Eilis J ^a   Lyytinen, Jukka ^d   Reunanen, Antti ^c   Laden, Francine ^a,b   Altshul, Larisa ^a,e   Ascherio, Alberto ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e Environmental Health and Engineering   (United States)

Author keywords

Epidemiology; Organochlorines; Parkinson's disease; Prospective; Toxicology

Indexed keywords

CHOLESTEROL; POLYCHLORINATED BIPHENYL; TRIACYLGLYCEROL;

ADULT; AGE; AGRICULTURAL WORKER; ARTICLE; BLOOD LEVEL; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; GEOGRAPHY; HUMAN; HYPERTENSION; INDUSTRIAL WORKER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OCCUPATION; PARKINSON DISEASE; PRIORITY JOURNAL; RESIDENTIAL AREA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEROLOGY; SMOKING; SYSTOLIC BLOOD PRESSURE; TREND STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYCHLORINATED BIPHENYLS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84870356279     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25217     Document Type: Article

References (41)

1. Brown RC, Lockwood AH, Sonawane BR. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 2005; 113: 1250-1256.
2. Elbaz A, Moisan F. Update in the epidemiology of Parkinson's disease. Curr Opin Neurol 2008; 21: 454-460.
3. Zhou C, Huang Y, Przedborski S. Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 2008; 1147: 93-104.
4. Steenland K, Hein MJ, Cassinelli RT 2nd, et al. Polychlorinated biphenyls and neurodegenerative disease mortality in an occupational cohort. Epidemiology 2006; 17: 8-13.
5. Petersen MS, Halling J, Bech S, et al. Impact of dietary exposure to food contaminants on the risk of Parkinson's disease. Neurotoxicology 2008; 29: 584-590.
6. Koldkjaer OG, Wermuth L, Bjerregaard P. Parkinson's disease among Inuit in Greenland: organochlorines as risk factors. Int J Circumpolar Health 2004; 63 (Suppl 2): 366-368.
7. Corrigan FM, Murray L, Wyatt CL, Shore RF. Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp Neurol 1998; 150: 339-342.
8. Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A 2000; 59: 229-234.
9. Knekt P, Aromaa A, Maatela J, et al. Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol 1988; 127: 28-41.
10. Smallwood AW, DeBord KE, Teass A. Polychlorobiphenyls in Serum. 4th ed. NIOSH/DBBS; 1994.
11. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatr.y 2008; 79: 368-376.
12. Schrag A, Ben-Shlomo Y, Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community? J Neurol Neurosurg Psychiatry 2002; 73: 529-534.
13. Korrick SA, Altshul LM, Tolbert PE, Burse VW, Needham LL, Monson RR. Measurement of PCBs, DDE, and hexachlorobenzene in cord blood from infants born in towns adjacent to a PCB-contaminated waste site. J Expo Anal Environ Epidemiol 2000; 10: 743-754.
14. Phillips DL, Pirkle JL, Burse VW, Bernert JT Jr, Henderson LO, Needham LL. Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol 1989; 18: 495-500.
15. Brookmeyer R, Liang KY, Linet M. Matched case-control designs and overmatched analyses. Am J Epidemiol 1986; 124: 693-701.
16. Greenland S. Applications of stratified analysis methods. In: Rothman KJ, Greenland S, eds. Modern Epidemiology. Philadelphia, PA: Lippincott-Raven Publishers; 1998: 281-300.
17. Longnecker MP, Wolff MS, Gladen BC, et al. Comparison of polychlorinated biphenyl levels across studies of human neurodevelopment. Environ Health Perspect 2003; 111: 65-70.
18. Van den Berg M, Birnbaum LS, Denison M, et al. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 2006; 93: 223-241.
19. Schisterman EF, Whitcomb BW, Louis GM, Louis TA. Lipid adjustment in the analysis of environmental contaminants and human health risks. Environ Health Perspect 2005; 113: 853-857.
20. Weisskopf MG, Knekt P, O'Reilly EJ, et al. Persistent organochlorine pesticides in serum and risk of Parkinson disease. Neurology 2010; 74: 1055-1061.
21. National Center for Environmental Health, Centers for Disease Control and Prevention. Third National Report on Human Exposure to Environmental Chemicals. Atlanta, GA: Department of Health and Human Services; 2005. Report No. NCEH Pub. No. 05-0570.
22. Seegal RF, Fitzgerald EF, Hills EA, et al. Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval. J Expo Sci Environ Epidemiol 2011; 21: 234-246.
23. Faroon O, Jones D, de Rosa C. Effects of polychlorinated biphenyls on the nervous system. Toxicol Ind Health 2001; 16: 305-333.
24. Fonnum F, Mariussen E, Reistad T. Molecular mechanisms involved in the toxic effects of polychlorinated biphenyls (PCBs) and brominated flame retardants (BFRs). J Toxicol Environ Health A 2006; 69: 21-35.
25. Seegal RF, Marek KL, Seibyl JP, et al. Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: a beta-CIT imaging study. Neurobiol Dis 2010; 38: 219-225.
26. Elbaz A, Tranchant C. Epidemiologic studies of environmental exposures in Parkinson's disease. J Neurol Sci 2007; 262: 37-44.
27. Tilson HA, Kodavanti PR. The neurotoxicity of polychlorinated biphenyls. Neurotoxicology 1998; 19: 517-525.
28. Bandiera SM. Cytochrome P450 enzymes as biomarkers of PCB exposure and modulators of toxicity. In: Robertson LW, Hansen LG, eds. PCBs: Recent Advances in Environmental Toxicology and Health Effects. Lexington, KY: The University Press of Kentucky; 2001: 185-192.
29. McLemore TL, Adelberg S, Liu MC, et al. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 1990; 82: 1333-1339.
30. Miksys S, Tyndale RF. Nicotine induces brain CYP enzymes: relevance to Parkinson's disease. J Neural Transm Suppl. 2006: 177-180.
31. Fischer LJ, Seegal RF, Ganey PE, Pessah IN, Kodavanti PR. Symposium overview: toxicity of non-coplanar PCBs. Toxicol Sci 1998; 41: 49-61.
32. Connor K, Ramamoorthy K, Moore M, et al. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Toxicol Appl Pharmacol 1997; 145: 111-123.
33. Cooke PS, Sato T, Buchanan DL. Disruption of steroid hormone signalling by PCBs. In: Robertson LW, Hansen LG, eds. PCBs: Recent Advances in Environmental Toxicology and Health Effects. Lexington, KY: The University Press of Kentucky; 2001: 257-263.
34. Bourque M, Dluzen DE, Di Paolo T. Neuroprotective actions of sex steroids in Parkinson's disease. Front Neuroendocrinol 2009; 30: 142-157.
35. Ragonese P, D'Amelio M, Savettieri G. Implications for estrogens in Parkinson's disease: an epidemiological approach. Ann N Y Acad Sci 2006; 1089: 373-382.
36. Ebner KV, Braselton WE Jr. Structural and chemical requirements for hydroxychlorobiphenyls to uncouple rat liver mitochondria and potentiation of uncoupling with aroclor 1254. Chem Biol Interact 1987; 63: 139-155.
37. Narasimhan TR, Kim HL, Safe SH. Effects of hydroxylated polychlorinated biphenyls on mouse liver mitochondrial oxidative phosphorylation. J Biochem Toxicol 1991; 6: 229-236.
38. Rohas LM, St-Pierre J, Uldry M, Jager S, Handschin C, Spiegelman BM. A fundamental system of cellular energy homeostasis regulated by PGC-1alpha. Proc Natl Acad Sci U S A. 2007; 104: 7933-7938.
39. Zheng B, Liao Z, Locascio JJ, et al. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med 2010; 2: 52ra73.
40. National Implementation Plan for the Stockholm Convention on Persistent Organic Pollutants: Finland. In: Stockholm Convention on Persistent Organic Pollutants (POPs): National Implementation Plans. Geneva, Switzerland: United Nations Environment Programme (UNEP); 2006.
41. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001; 57: 1497-1499.